Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SnoreCare appears to be an active digital health company/product focused on consumer sleep monitoring for snoring and sleep apnea awareness. Its mobile app records overnight audio, uses on-device machine learning to detect and analyze snoring events, provides a snore score and trend analytics, and includes an AI-powered sleep apnea risk assessment and sleep coaching features. The product is positioned as a wellness and screening-support tool rather than a therapeutic drug developer, and there is no evidence that it operates a traditional biotech or pharmaceutical pipeline. Available evidence links the iOS app to Apparent Group Limited as developer, while Android listings also reference SnoreCare KMS, suggesting the brand may operate through multiple publishing entities or trade names. Overall, SnoreCare is best characterized as a commercial consumer sleep-health technology business rather than a biotech, pharma, or therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SnoreCare.